SCIENTIFIC PROGRAM
Friday, 14 February 2020
15:00 - 15:20 Opening Ceremony
  Dr. Kerim Guler (Turkish Society of Internal Medicine) 
Dr. Miklos Szathmari (Hungarian Society of Internal Medicine)
 
15:20 - 16:00 Session 1
  Chairs: Miklos Szathmari, Kerim Guler
15:20 - 15:40 Ischemic heart disease – acute coronary syndrome David Becker
15:40 - 16:00 Management of Diabetes in Rheumatological Diseases Kubilay Ukinc
16:00 - 17:00 Session 2
  Chairs: Sedat Kiraz, Server Serdaroğlu
16:00 - 16:20 Heart failure – Atrial fibrillation György Bárczi
16:20 - 16:40 Comprehensive Management of Spondyloarthritis with extra-articular manifestations Timur Pırıldar
16:40 - 17:00 Non-Radiographic Axial SpA: A Women's Disease? Cemal Bes
17:00 - 17:20 COFFEE BREAK 
17:20 - 18:20 Session 3
  Chairs: Vedat HamuryudanÖmer Kuru
17:20 - 17:40 Late maternal consequences of gestational diabetes Ádám Gy. Tabák
17:40 - 18:20 Diagnosis and treatment for hyperuricemia and gout: Is uric acid friend or foe?  Yunus Erdem
İhsan Ertenli
18:20 - 18:50 Case Presentations
Chair: Sema Yılmaz
  • Resistance to anti-Tuberculosis Drugs in Turkey and Worldwide
    Dr. Hatice Yazısız
  • Insidance of Akylosing Spondylitis Among Patients With Urinary Tomography
    Dr. Orhan Eren
  • A Rare Disease of Mimicking Scleroderma: Werner Syndrome
    Dr. Ozan Cemal İçaçan
  • Femoral Fracture After Long-term usage of bisphosphonates: A Case Report
    Dr. Sevgi Atar
 
Saturday, 15 February 2020
09:00 - 09:40 Session 4
  Chairs:András Tislér, Eftal Yücel
09:00 - 09:20 Renoprotective mechanisms of SGLT2 inhibitors András Tislér
09:20 - 09:40 Diagnosis and Management of non-infectious Uveitis Sibel Kadayıfçılar
09:40 - 10:00 How to Manage Behçet's Disease Ali Taylan
10:00 - 11:00 Session 5
  Chairs: László Herszényi, Göksal Keskin
10:00 - 10:20 New aspects of acid-related disorders László Herszényi
10:20 - 10:40 Manifestations and Management of Psoriasis Emel Bülbül Başkan
10:40 - 11:00 Can Transition from Psoriasis to PsA be Prevented? Umut Kalyoncu
11:00 - 11:20 COFFEE BREAK 
11:20 - 12:20 Session 6
  Chairs: Kenan AkgünSüleyman Özbek
11:20 - 11:40 Treatment and Follow-up Approach to Pregnant Rheumatoid Arthritis Patients: Update on pregnancy, lactation and fertility Zeynep Özbalkan Aşlar
11:40 - 12:00 Management of ANCA Associated Vasculitis Ali Şahin
12:00 - 13:00 Lunch 
13:00 - 13:40 Session 7
  Chairs: Szalay Ferenc, Tufan Tukek
13:00 - 13:20 Vaccination as an effective preventive measure in adult medicine Serhat Unal
13:20 - 13:40 Hepatitis C - experiences with the new treatment options Szalay Ferenc 
13:40 - 14:40 Session 8
  Chairs: Meltem Melikoğlu, Veli Yazisiz
13:40 - 14:00 Biological therapy in arthritis patients with hepatitis B or C infection? Feride Nur Göğüş
14:00 - 14:20 Managing Extra-articular manifestaions in Rheumatoid arthritis? Fulya Coşan
14:20 - 14:40 How to treat paradoxal psoriasis in patients with rheumatoid arthritis Serhat İnalöz
14:40 - 15:00 COFFEE BREAK 
15:00 - 16:00 Session 9
  Chair: Taşkın Şentürk
15:00 - 15:20 Role of ultrasonography in the diagnosis of rheumatic diseases in light of ACR/EULAR guidelines  Salih Pay
15:20 - 15:40 MRI for diagnosis of axial spondyloarthritis: major advance with critical limitations Ömer Karadağ
15:40 - 16:00 Nailfold Capillaroscopy in Rheumatic Diseases: Which Parameters Should Be Evaluated? Hakan Erdem
16:00 - 17:00 Session 10
  Chairs: Timuçin KaşifoğluFatoş Önen
16:00 - 16:20 Update on the management of Fibromialgia Lale Altan İnceoğlu
16:20 - 16:40 New EULAR recommendations for the management of systemic lupus erythematosus Emel Gönüllü
16:40 - 17:00 Prevention and treatment of glucocorticoid-induced osteoporosis İlker Yağcı
17:00 - 17:50 Case Presentations
Chairs: Adem Küçük, Rıdvan Mercan
  • Clinical Manifestations of Wegener Syndrome Patients
    Dr. Yusuf Karabulut
  • Reviewing Tuberculosis Associated Arthritis With Two Cases
    Dr. Fatih Sarıtaş
  • Comparison of serum parathormone, vitamin D, calcium , phosphorus, albümin and alkaline phosphatase levels in patients with atrial fibrilation and control group
    Dr. Mehmet Emin Derin
  • Anti-TNFs Safety Profile in patients with Ankylosing Spondylitis
    Dr. Esra Kayacan
  • Neutrophil Lymphocyte Ratio ; an alternative inflammatory marker for rheumatoid arthritis disease activity.
    Dr. Yeliz Zahiroğlu
  • Can Tocilizumab be an alternative for the treatment of Steroid Resistant Uveitis
    Dr. Suade Özlem Badak
   
Sunday, 16 February 2020

08:20 - 09:20

Session 11

 

Chairs: Serhat İnalöz, Mehmet Akif Öztürk

08:20 - 08:40

JAK In hibitors: New Players in Rheumatoid Arthritis Treatment Mehmet Engin Tezcan

08:40 - 09:00

Does interleukin-23 (IL-23) inhibitors change the course of treatment in Psoriasis and Psoriatic Arthritis? Zeynep Topkarci

09:00 - 09:20

When to Escalate and Taper the Biologics? Uğur Karasu
09:20 - 09:35 COFFEE BREAK 

09:35 - 10:15

Session 12

 

Chairs: Remzi Cevik, Akın Erdal

09:35 - 09:55

Quantitative Methods To Evaluate Skin Involvement in Systemic Sclerosis Duygu Karadağ

09:55 - 10:15

Management of Drug Induced Osteoporosis Kenan Akgün
10:15 - 10:45 Case Presentations
Chair: Şükran Erten
  • Systemic Lupus Erythematosus Patient With Pauci-Immune Glomerulonephritis and pANCA Positivity
    Dr. Serdar Can Güven
  • Relationship Between Vitamin D Levels and Resless Leg Syndrome in Patients With Falimial Mediterranean Fever
    Dr. Serpil Ergülü Eşmen
  • Gaint Cell Arthritis: A Single Center Experience
    Dr. Ayşe Bahar Keleşoğlu Dinçer
  • Prevelance of Functional Bowel Diseases in Light of Diagnostic Criteria of Rome IV Functional Bowel Diseases in Patients With Primary Sjogren Syndrome
    Dr. Samet Karahan
  • Evaluation of the Relationship between Clinical and Laboratory Treatment Response and BECK's Depression, BECK's Anxiety and Hospital Anxiety and Depression Scales in Patients with Rheumatoid Arthritis.
    Dr. Merve Sungur Özgünen